Sumitomo Pharma Co Ltd
TSE:4506
Gross Margin
Sumitomo Pharma Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | JP |
| Market Cap | 134.7B JPY |
| Gross Margin |
60%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 744.3B USD |
| Gross Margin |
80%
|
| Country | DK |
| Market Cap | 4T DKK |
| Gross Margin |
85%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 364.1B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 331.8B USD |
| Gross Margin |
75%
|
| Country | UK |
| Market Cap | 187.5B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 189B CHF |
| Gross Margin |
73%
|
| Country | CH |
| Market Cap | 182.7B CHF |
| Gross Margin |
74%
|
| Country | US |
| Market Cap | 161.7B USD |
| Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Sumitomo Pharma Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Sumitomo Pharma Co Ltd's most recent financial statements, the company has Gross Margin of 59.9%.
You don't have any saved screeners yet
